What was recalled
The U.S. Consumer Product Safety Commission (CPSC) has issued a recall involving a specific batch of Benadryl Liquid Elixir distributed under the brand name Arsell. This action was taken following an investigation into packaging compliance, specifically regarding the safety standards required for over-the-counter medications that carry risks for young children. The recall announcement was made on March 20, 2025, and it targets a single product configuration: the 100 mL bottle of Benadryl Liquid Elixir. It is important to note that this recall applies strictly to the physical packaging of the product sold by Arsell; the active pharmaceutical ingredient itself is not considered defective, but the vessel holding it failed to meet federal safety mandates.
To help you determine if your household possesses the affected item, please examine your medicine cabinet or storage area for a round, dark plastic bottle. The bottle features a distinctive label on the front that combines pink and white design elements, with the word "Benadryl" printed prominently in blue text. Inside this bottle is 100 mL of the liquid elixir. Crucially, while the medicine inside may appear normal, the outer container lacks the mandatory child-resistant closure mechanism required by law for diphenhydramine products. The product was originally packaged in a paper box that mirrors the bottle’s aesthetic, decorated with pink and white graphics and the same blue "Benadryl" branding. On the bottom of this cardboard box, you will find a white label with black text displaying the specific code "X003VRIGUL." This code is the primary identifier for the recalled lot.
The affected products were sold exclusively through Amazon.com. The CPSC has identified that these items were distributed via this online retailer, and they are currently working to identify all known purchasers of this specific inventory. Because the distribution channel was limited to Amazon, if you purchased a Benadryl product from a different physical pharmacy or grocery store, it is highly likely not part of this specific recall, provided it does not bear the Arsell brand and the specific packaging described above. The scope of this recall is narrow but significant due to the nature of the hazard: while the medicine is effective for allergies, its delivery system was found to be dangerously accessible to children.
In total, the recall encompasses all units of this specific 100 mL Arsell-branded Benadryl Liquid Elixir sold in the non-child-resistant packaging described. The CPSC and Arsell are treating this as a serious compliance violation because diphenhydramine, the active ingredient, can be toxic to young children even in small amounts. The agency is not reporting any incidents or injuries at this time, but the potential for harm exists whenever a child can access the bottle without adult assistance. If you have this product, particularly if it matches the visual description and bears the code X003VRIGUL on the box bottom, it falls squarely within the scope of this recall.
The hazard, explained
At the heart of this recall is a simple but dangerous mismatch between a potent medication and its container. The specific issue involves Arsell’s Benadryl Liquid Elixir, which contains diphenhydramine, an antihistamine commonly used to treat allergy symptoms. While diphenhydramine is generally safe for adults when taken as directed, it carries significant risks if ingested by young children. The core problem here is not the medicine itself, but the fact that the 100 mL bottles were sold in packaging that does not meet federal safety standards. Specifically, the bottle and its outer box lack child-resistant closures, which are legally required under the Poison Prevention Packaging Act for over-the-counter drugs containing dangerous levels of certain active ingredients.
To understand why this matters, it helps to look at how children interact with their environment. Toddlers and young children are naturally curious and often explore the world by putting objects in their mouths. They do not have the fine motor skills or the cognitive understanding to operate complex latches or push-and-turn caps designed to thwart them. Standard plastic bottles, even those that feel sturdy to an adult, can often be opened with relative ease by a determined child. When a bottle lacks a certified child-resistant mechanism, it essentially becomes an open invitation for accidental ingestion. The liquid inside is easily accessible, and because it is in a concentrated form, the margin for error is extremely small.
The physiological impact of diphenhydramine poisoning in children can be severe and rapid. Unlike some mild irritants that might cause only stomach upset, antihistamines like diphenhydramine affect the central nervous system. In young bodies, which process medications differently than adults, even a small amount intended for an adult can lead to serious toxicity. Symptoms of poisoning can include extreme drowsiness or agitation, hallucinations, rapid heart rate, seizures, and difficulty breathing. In worst-case scenarios, accidental overdose can be life-threatening. This is precisely why the federal government mandates child-resistant packaging for such products: it acts as a critical physical barrier to buy parents and caregivers time to notice and intervene before a tragedy occurs.
In this specific case, the Arsell product was packaged in a round dark plastic bottle with a pink and white label, housed in a matching paper box. While the branding is clear, the packaging design failed to incorporate the necessary safety features. The absence of these features means that any child who can reach the shelf where this item is stored has direct access to the hazardous contents. This is not a minor oversight; it is a fundamental failure of the safety protocols designed to protect the most vulnerable consumers from accidental harm.
Who is most at risk
The primary group at immediate risk from this Arsell Benadryl recall consists of young children, particularly those under the age of six. This vulnerability stems not from the medication itself, which is a common and generally safe antihistamine for allergic reactions when used correctly, but from the specific failure in packaging design that triggered this recall. The Poison Prevention Packaging Act mandates that over-the-counter medications containing potentially harmful doses for small bodies must be secured in child-resistant containers. Because the 100 mL bottle sold by Arsell lacks these mandatory safety features, it presents a direct and accessible pathway for accidental ingestion. Toddlers and preschoolers are naturally curious explorers who often mimic adult behaviors, such as taking medicine to "feel better," or they may simply mistake the colorful pink and white packaging for candy or juice due to its bright labeling. Without a child-resistant cap that requires simultaneous pushing and turning to open, a determined child can easily unscrew the lid, making the liquid diphenhydramine instantly accessible.
The severity of the risk is driven by the pharmacological effects of diphenhydramine on developing bodies. Even a small amount of this medication, which might be harmless or therapeutic for an adult, can lead to severe poisoning in a child. Young metabolisms process drugs differently than adults, meaning that a dose intended for symptom relief can quickly become toxic. The symptoms of such poisoning are not always obvious at first glance; they can include extreme drowsiness, confusion, hallucinations, rapid heartbeat, and in worst-case scenarios, seizures or respiratory distress. Because children cannot articulate their symptoms clearly until they are in significant distress, the lack of immediate visual cues that a bottle has been tampered with—combined with the ease of opening the non-compliant container—creates a dangerous window where exposure can occur before a caregiver realizes something is wrong.
While infants and toddlers are the most vulnerable demographic due to their physical size and developmental stage, households with multiple caregivers or frequent visitors also face heightened risk. In busy homes where bottles are moved quickly from shelves to nightstands or bags, the absence of a distinct child-resistant mechanism means that standard carelessness can lead to tragedy. Additionally, while this recall is specifically targeted at children due to the federal regulation cited, it is important to note that elderly individuals with cognitive impairments may also be at risk if they are prone to wandering or misidentifying medications. However, the CPSC’s classification of this hazard is explicitly tied to child safety standards. Therefore, any adult in the household who is responsible for storing medication must recognize that the default assumption—that a plastic bottle on a shelf is secure—is no longer valid for this specific Arsell product. The risk is not theoretical; it is an open door created by a regulatory violation that places the burden of safety entirely on the consumer until a refund is processed.
How to tell if you have the recalled item
Before you take any action or contact Arsell for a refund, it is critical that you confirm exactly which product you possess. Because this recall targets a specific packaging defect rather than a problem with the medicine’s formula, distinguishing the affected bottles from safe alternatives requires careful attention to physical details. You need to locate the 100 mL bottle of Benadryl Liquid Elixir and examine it against the specific criteria outlined by the Consumer Product Safety Commission (CPSC). The danger lies in the packaging, so your verification process must focus entirely on how the product is contained and labeled.
First, inspect the bottle itself. The recalled items are packaged in a round, dark plastic bottle. This is a distinct visual cue; if your bottle is clear glass, square-shaped, or made of a different type of plastic, it is likely not part of this specific recall batch. Next, look at the label on the front of the bottle. You are looking for a design that features pink and white colors. The brand name "Benadryl" must be printed in blue text against this background. If the text color or the label scheme differs from this description, you can likely rule out this specific recall.
Turn the bottle around to examine the back label. This area contains important safety disclosures, storage instructions, and manufacturer information, but for identification purposes, it serves primarily to confirm that you are holding a legitimate Arsell product. More importantly, look at the bottom of the package. The recalled items were originally sold in a paper box decorated with pink and white designs, also featuring "Benadryl" written in blue text. On the bottom of this box, there is a white label with black text. You must find the specific code "X003VRIGUL." This alphanumeric code is the definitive identifier for this recall. If you cannot find this exact code on the bottom label, the item is not part of this specific safety alert.
Finally, consider where and how you purchased the item. This recall specifically involves units sold on Amazon.com. While this does not rule out other distribution channels entirely, it is the primary source identified in the official report. If you bought the product through a different retailer and cannot find the "X003VRIGUL" code, your risk profile may be different. However, if you have an Amazon order history, check it for purchases matching this description. Remember, only the bottle is being recalled, not the medicine itself, but because the packaging violates the Poison Prevention Packaging Act, both the contents and the container should be treated with caution until you dispose of them properly.
What to do — step by step
If you believe you have purchased the recalled Arsell Benadryl Liquid Elixir, your immediate priority is securing safety for any children in your household. The risk here is serious because the packaging does not meet federal child-resistant standards, meaning a young child could easily open the bottle and ingest the medication. Therefore, your first and most critical step is to immediately remove the product from your home environment. Do not leave it on a nightstand, in a bathroom cabinet, or anywhere within sight or reach of a child. Treat this item as if it were an unlocked container of hazardous material until you have completed the disposal process. Once secured away from children, do not attempt to use the medication for its intended purpose.
The second step involves properly disposing of both the bottle and the remaining liquid medicine. While the recall notice specifies that only the bottle is being recalled due to the packaging defect, it explicitly instructs consumers to dispose of both the container and the contents together. You should not attempt to transfer the liquid to a different container or try to seal the existing cap more tightly. Instead, place the entire unit in your household trash in a way that prevents anyone, particularly children or pets, from retrieving it. This ensures that the diphenhydramine inside cannot be accessed by accident. If you are unsure about local disposal guidelines for medications, check with your local waste management authority, but do not delay the removal of the item from your living space.
Once the product is safely discarded, you must contact Arsell to initiate your refund. The company has established a dedicated email address for this purpose: recall@arsellsupport.com. When you write to them, you will need to provide specific documentation to verify your purchase and confirm that you have followed safety instructions. Specifically, you are required to submit your original Amazon order number. This helps Arsell match your claim to their sales records on the platform where the product was sold.
In addition to your order number, Arsell requires a photo demonstrating that you have disposed of the recalled Benadryl. Please take a clear picture showing the bottle and medicine in the trash or being discarded. This visual proof is a standard part of their remedy process to ensure consumer safety compliance. Send these two items—your Amazon order number and the disposal photo—to the email address provided. Arsell has stated they will provide a full refund for this item. They are also actively contacting known purchasers directly, so keep an eye on your email or Amazon account notifications for any updates from them. By following these steps precisely, you ensure that you are not only protected from potential harm but also eligible for the financial remedy offered by the manufacturer.
Your refund, repair, or replacement options
When a product is recalled due to a safety violation like the one involving Arsell’s Benadryl Liquid Elixir, the primary goal is to remove the hazard from your home and make you whole financially. In this specific case, the remedy is straightforward and consumer-friendly: you are entitled to a full refund. It is important to understand that because the issue lies with the packaging rather than the chemical composition of the medicine itself, there is no option for a "repair." You also cannot simply exchange the bottle for another one of the same product, as the defective packaging is part of the recall scope. Instead, the process is designed to be entirely about returning your money so you can purchase a safer alternative from a different source if you choose.
To initiate this refund, Arsell has established a dedicated email channel for recall claims. You will need to contact them directly at recall@arsellsupport.com. This is not a general customer service inquiry; it is a specific processing line for this recall event. When you send your email, you must include two specific pieces of information to prove your eligibility and verify the disposal of the item. First, you must provide your Amazon order number. This allows Arsell to cross-reference their records with Amazon’s sales data to confirm that you purchased this specific batch of product. Second, you are required to submit a clear photo demonstrating that you have disposed of the recalled Benadryl. This step is critical for safety compliance; it proves that the non-child-resistant bottle is no longer accessible to anyone in your household.
The instructions from Arsell are quite specific about what should be disposed of. While the recall notice technically targets the bottle due to the packaging violation, they explicitly state that both the bottle and the medicine inside should be thrown away. This might feel counterintuitive since the diphenhydramine itself is not the problem, but keeping the liquid in a non-compliant container poses an ongoing risk if you were to repurpose it or if someone else accessed it. Therefore, do not try to save the liquid for later use. Dispose of the entire contents securely before taking the photo for your refund claim.
Once you have emailed your order number and the disposal photo to Arsell, they will process your full refund. The company has stated that all known purchasers are being contacted directly, which means you may hear from them even if you do not take the first step. However, taking proactive action is the safest way to ensure you are compensated promptly and that the hazardous item is removed from your possession. By following these steps, you close the loop on this recall, ensuring your family’s safety and recovering your funds without any hassle.
What can happen if you ignore it
When a recall is issued due to a failure in child-resistant packaging, the danger is not abstract; it is immediate and physiological. The primary risk here stems from the fact that the Arsell Benadryl Liquid Elixir was sold in standard plastic bottles that do not meet the stringent requirements of the Poison Prevention Packaging Act. This means that any container holding this medication can be opened by a young child with surprising ease. Children, particularly those under five years old, are naturally curious and often explore their environment by putting objects in their mouths. Without a locking cap or specialized barrier, the bottle becomes an accessible vessel for a potentially lethal dose of diphenhydramine. Diphenhydramine is a potent antihistamine that affects the central nervous system. In adults, the recommended dosage is carefully calculated to provide relief from allergies without causing significant sedation or other side effects. However, for a small child, even a fraction of the adult dose can be dangerous. If a child ingests the liquid because they could not be stopped by a child-proof cap, the consequences can range from severe drowsiness and confusion to more critical outcomes such as seizures, rapid heart rate, difficulty breathing, or coma. The risk is compounded by the fact that the product was sold in a 100 mL bottle, which contains enough medication for multiple adult doses but could represent an overdose for a toddler in just one or two sips. It is important to note that, according to the official recall facts from the CPSC, there have been no reported incidents of injury or poisoning associated with this specific batch of Arsell Benadryl as of the recall date of March 20, 2025. This absence of reported cases should not be interpreted as proof that the product is safe to keep. It simply means that, so far, families have not yet suffered harm. However, the potential for harm exists solely because the packaging failed to prevent access. Ignoring this recall means leaving a toxic substance within easy reach of those who cannot understand its purpose or danger. Continuing to use the product also creates a false sense of security. Parents and caregivers might assume that any bottle labeled "Benadryl" is safe to store on a high shelf or in a bathroom cabinet, not realizing that the specific packaging defect makes it vulnerable to curious hands. By disposing of the recalled item and securing your medication properly, you eliminate this preventable risk. The cost of waiting for a refund is minimal compared to the irreversible health impacts that could result from a child accessing unsecured medication. Do not wait for an incident to occur; act now to ensure the safety of your household.Staying safe: broader tips
While this specific recall highlights a critical failure in packaging compliance, it serves as a valuable reminder that child safety often hinges on the small details we might otherwise overlook. When it comes to over-the-counter medications and household chemicals, the "child-resistant" label is a legal standard, but true safety requires proactive habits. One of the most effective ways to prevent accidental ingestion is to store all medicines and cleaning products in high, locked cabinets or drawers that are completely out of a child’s sight and reach. Visibility is a powerful trigger for curiosity; if a child cannot see a bottle sitting on a counter or in an open bathroom cabinet, they are significantly less likely to attempt to retrieve it. Furthermore, relying solely on the cap’s locking mechanism can be risky because children are often more dexterous and persistent than manufacturers anticipate. Always double-check that caps are fully tightened until you hear the distinct click indicating they are locked.
Another essential practice is to never refer to medicine as "candy" when explaining it to a child. Doing so can create dangerous associations, leading a curious toddler to seek out colorful pills or liquids in the future. Instead, use clear, firm language such as "this is medicine and it is only for grown-ups" or "this is not food." Consistency in messaging helps reinforce boundaries early on. Additionally, consider the placement of your storage containers. Many accidents occur when parents temporarily set a medication bottle down on a table or nightstand before putting it away, only to be interrupted by a phone call or another task. Make it a rule that once you open a container for use, it must be returned to its secure location immediately, without exception.
It is also wise to periodically audit your home’s safety landscape by checking the Consumer Product Safety Commission (CPSC) website and signing up for their email alerts. Recalls happen frequently, and new hazards are identified regularly as products are tested and monitored in the real world. By staying informed, you can act quickly before a potential issue becomes an emergency. Finally, ensure that your home’s emergency numbers, including the Poison Control Center hotline (1-800-222-1222), are saved in your phone under an easily accessible name like "Poison Help." This preparation ensures that if a mistake ever happens, you can act with speed and confidence. Remember, prevention is built on layers of vigilance, smart storage, and constant awareness of the environment around your little ones.